Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-03-13
DOI
10.1038/s41598-018-23140-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel
- (2017) Marion Paolini et al. International Journal of Nanomedicine
- Drug Development of Therapeutic Monoclonal Antibodies
- (2016) Diane R. Mould et al. BIODRUGS
- Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics
- (2016) Katherine L. Gill et al. CLINICAL PHARMACOKINETICS
- Chemotherapy-induced peripheral neuropathy: Current status and progress
- (2016) Jamie R. Brewer et al. GYNECOLOGIC ONCOLOGY
- Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination
- (2016) Yi-Nan Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Antibody–drug conjugates for cancer therapy
- (2016) Anish Thomas et al. LANCET ONCOLOGY
- Cellular distribution of injected PLGA-nanoparticles in the liver
- (2016) Jin-Kyu Park et al. Nanomedicine-Nanotechnology Biology and Medicine
- Inter-patient variability in docetaxel pharmacokinetics: A review
- (2015) Annemieke J.M. Nieuweboer et al. CANCER TREATMENT REVIEWS
- Safety of Nanoparticles in Medicine
- (2015) Joy Wolfram et al. CURRENT DRUG TARGETS
- Immunosuppressive drug therapy – biopharmaceutical challenges and remedies
- (2015) Saba Khan et al. Expert Opinion on Drug Delivery
- Formulation and physiologic factors affecting the pharmacology of carrier-mediated anticancer agents
- (2015) Andrew T Lucas et al. Expert Opinion on Drug Metabolism & Toxicology
- FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin
- (2015) Michal Pyzik et al. JOURNAL OF IMMUNOLOGY
- Targeting FcRn for the modulation of antibody dynamics
- (2015) E. Sally Ward et al. MOLECULAR IMMUNOLOGY
- RES blockade: A strategy for boosting efficiency of nanoparticle drug
- (2015) Ting Liu et al. Nano Today
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- Toxicity of targeted therapy: Implications for response and impact of genetic polymorphisms
- (2014) Sariah Liu et al. CANCER TREATMENT REVIEWS
- Impact of CYP polymorphisms, ethnicity and sex differences in metabolism on dosing strategies: the case of efavirenz
- (2014) Panjasaram Naidoo et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior
- (2014) Huile Gao et al. Expert Opinion on Drug Delivery
- State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines
- (2014) Charlene M. Dawidczyk et al. JOURNAL OF CONTROLLED RELEASE
- Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
- (2014) Samir Mitragotri et al. NATURE REVIEWS DRUG DISCOVERY
- Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid
- (2013) Li Liu et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
- (2013) Mark J. Ernsting et al. JOURNAL OF CONTROLLED RELEASE
- Matching cellular dimensions with molecular sizes
- (2013) Michael Reth NATURE IMMUNOLOGY
- Engineering multifunctional nanoparticles: all-in-one versus one-for-all
- (2013) Elizabeth Huynh et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Pathogenesis of Hand-Foot Syndrome induced by PEG-modified liposomal Doxorubicin
- (2013) Noriyuki Yokomichi et al. Human Cell
- Renal Transporters in Drug Development
- (2012) Kari M. Morrissey et al. Annual Review of Pharmacology and Toxicology
- Loss of orally administered drugs in GI tract
- (2012) Yogeshkumar Nanasaheb Gavhane et al. SAUDI PHARMACEUTICAL JOURNAL
- The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles
- (2011) Kai Xiao et al. BIOMATERIALS
- In vivobiodistribution of nanoparticles
- (2011) Joao Paulo Mattos Almeida et al. Nanomedicine
- Relieving PEGylation
- (2011) Matthew C. Parrott et al. Nature Chemistry
- Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Ron J. Keizer et al. CLINICAL PHARMACOKINETICS
- Effect of mechanical properties of hydrogel nanoparticles on macrophage cell uptake
- (2009) Xavier Banquy et al. Soft Matter
- Controlled drug delivery in tissue engineering
- (2007) Marco Biondi et al. ADVANCED DRUG DELIVERY REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now